Asymptomatic dengue infection in a cuban population confirms the protective role of the RR variant of the FcγRIIa polymorphism

American Journal of Tropical Medicine and Hygiene

Volumn 82, Issue 6, 2010, Pages 1153-1156

  García, Gissel ^a   Sierra, Beatriz ^a   Pérez, Ana B ^a   Aguirre, Eglys ^a   Rosado, Ileana ^b   Gonzalez, Narjara ^c   Izquierdo, Alienys ^a   Pupo, Maritza ^e   Ruiz, Didye ^a   Díaz, Danay ^a   Sánchez, Lizet ^a   Marcheco, Beatriz ^b   Hirayama, Kenji ^d   Guzmán, María G ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b National Center of Medical Genetics   (Cuba)

^c CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

^d NAGASAKI UNIVERSITY   (Japan)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR IIA; IMMUNOGLOBULIN G;

ADULT; AGED; ALLELE; ARTICLE; CUBA; DENGUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DNA POLYMORPHISM; FEMALE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEMORRHAGIC FEVER; HUMAN; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; MALE; PHAGOCYTOSIS; POPULATION GENETICS; PROTEIN BINDING; RISK REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; CUBA; DENGUE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, IGG; YOUNG ADULT;

EID: 77953749447     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.09-0353     Document Type: Article

References (30)

1. Byron E, Martina E, Koraka P, Albert D, Osterhaus ME, 2009. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22: 564-581.
2. Sierra B, Alegre R, Perez AB, Garcia G, Stum-Ramirez K, Guzmán MG, 2007. HLA A, B and DRB1 allele frequencies in Cuban individuals with antecedents of Dengue 2 disease. Advantages of the Cuban population for HLA studies of dengue virus infection. Hum Immunol 68: 531-540.
3. Loke H, Bethell DB, Phuong CX, Dung M, Schneider J, White NJ, Day NP, Farrar J, Hill AV, 2001. Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis 184: 1369-1373.
4. Chiewsilp P,Scott RM, Bhamarapravati N, 1981. Histocompatibility antigens and dengue hemorrhagic fever. Am J Trop Med Hyg 30: 1100-1105.
5. Lan NT, Kikuchi M, Huong VT, Ha do Q, Thuy TT, Tham VD, Tuan HM, Tuong VV, Nga CT, Van Dat T, Oyama T, Morita K, Yasunami M, Hirayama K, 2008. Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl Trop Dis 2: e304.
6. Loke H, Bethell D, Phuong CXT, Day N, White N, Farrar J, Hill A, 2002. Susceptibility to dengue hemorrhagic fever in Vietnam: evidence of an association with variation in the vitamin D receptor and Fc ganma receptor IIa genes. Am J Trop Hyg 67: 102-106.
7. Sakuntabhai A, Turbpaiboon C, Casademont I, Chuansumrit A, Lowhnoo T, Kajaste-Rudnitski A, Kalayanarooj SM, Tangnararatchakit K, Tangthawornchaikul N, Vasanawathana S, Chaiyaratana W, Yenchitsomanus PT, Suriyaphol P, Avirutnan P, Chokephaibulkit K, Matsuda F, Yoksan S, Jacob Y, Lathrop GM, Malasit P, Despres P, Julier C, 2005. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 37: 507-513. (Pubitemid 40617279)
8. Van de Winkel JGJ, Capel PJA, 1993. Hman IgG Fc receptor heterogenicity: molecular aspects and clinical implications. Immunol Today 14: 215-221.
9. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ, 1991. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol 147: 1338-1343.
10. Kimberly C, Altaf A, Lisa B, Steketee R, Bernard L, Ya Ping S, 2004. Polymorphism of Fc receptor IIafor immunoglobulin G is associated with placental malaria in HIV-1-positive women in Western Kenya. J Infect Dis 190: 1192-1198. (Pubitemid 39186808)
11. Guzman MG, Kouri G, 2008. Dengue haemorrhagic fever integral hypothesis: confirming observations. Trans R Soc Trop Med Hyg 102: 522-523.
12. Libel M, 2006. Brote de dengue en Cuba, 2006. Enfermedades infecciosas emergentes y reemergentes, Región de las Américas. Havana, Cuba: Organización Panamericana de la Salud.
13. WHO, 1997. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. Geneva: WHO, 2nd ed.
14. Vazquez S, Valdes O, Pupo M, Delgado I, Alvarez M, Pelegrino JL, Guzman MG, 2003. MAC-ELISA and ELISA inhibition methods for detection of antibodies after yellow fever vaccination. J Virol Methods 110: 179-184. (Pubitemid 36645262)
15. Vazquez S, Perez AB, Ruiz D, Rodriguez R, Pupo M, Calzada N, Gonzalez L, Gonzalez D, Castro O, Serrano T, Guzman MG, 2005. Serological markers during dengue 3 primary and secondary infections. J Clin Virol 33: 132-137.
16. Bazilio AP, Viana VST, Toledo R, Woronik V, Bonfá E, Monteiro RC, 2004. Fc ganma RIIa polymorphism: a susceptibility factor for inmune complex-mediated lupus nephritis in Brazilian patients. Nephrol Dial Transplant 19: 1427-1431.
17. Cooke G, Aucan C, Walley AJ, Segal SG, Greenwood B, Hill AVS, 2003. Association of Fc ganma receptor IIa (CD32) polymorphism with severe Malaria in West Africa. Am J Trop Hyg 69: 565-568.
18. Yee AM, Phan HM, Zuniga R, Salmon JE, Musher DM, 2000. Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis 30: 25-28. (Pubitemid 30067057)
19. Bossuyt X, Moens L, Van Hoeyveld E, Jeurissen A, Bogaert G, Sauer K, 2007. Coexistence of (partial) immune defects and risk of recurrent respiratory infections. Clin Chem 53: 1124-1130. (Pubitemid 46047772)
20. Koraka P, Suharti C, Setiati TE, Mairuhu AT, Van Gorp E, Hack CE, Juffrie M, Sutaryo J, Van Der Meer GM, Groen J, Osterhaus AD, 2001. Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J Clin Microbiol 39: 4332-4338. (Pubitemid 33117119)
21. van Sorge NM, van der Pol W-L, van de Winkel JGJ, 2003. FcgrR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 61: 189-202.
22. García E, Rosales C, 2002. Signal transduction during Fc receptor-mediated phagocytosis. J Leukoc Biol 72: 1092-1108. (Pubitemid 36008879)
23. Israelsson E, Vafa M, Maiga B, Lysén A, Iriemenam NC, Dolo A, Doumbo OK, Troye-Blomberg M, Berzins K, 2008. Differences in Fc gamma receptor IIa genotypes and IgG subclass pattern of anti-malarial antibodies between sympatric ethnic groups in Mali. Malar J 15: 175.
24. Forthal DN, Moog C, 2009. Fc receptor-mediated antiviral antibodies. Current Opinion in HIV and AIDS 4: 388-393.
25. Moi ML, Lim CHK, Takasaki T, Kurane I, 2010. Involvement of the Fcγ receptor IIA cytoplasmic domain in antibody dependent enhancement of dengue virus infection. J Gen Virol 91: 103-111.
26. Bruhns P, Iannascoli B, England P, Mancardi D, Fernández N, Jorieux S, Daeron M, 2009. Specificity and affinity of human Fc gamma receptor and their polymorphic variants for human IgG subclasses. Blood 113: 3716-3725.
27. García G, Rosado I, Sierra B, Pérez AB, Hirayama K, Guzmán MG, 2008. Variantes genotípicas del receptor de baja afinidad Fcγ II a en la poblacion cubana de Ciudad de la Habana. Revista Cubana de Genética Comunitaria 2: 46-51.
28. Lehrnbecher T, Foster CB, Zhu S, Leitman SF, Goldin LR, Huppi K, Chanock SJ, 1999. Variant genotypes of the low affinity Fcg receptors in two control populations and a review of low affinity receptor polymorphisms in control and disease population. Blood 94: 4220-4232.
29. Halstead S, 2006. Dengue in Americas and Southeast Asia: do they differ? Rev Panam Salud Publica 20: 407-115.
30. Sierra BC, Kourí G, Guzmán MG, 2007. Race: a risk factor for dengue hemorrhagic fever. Arch Virol 152: 533-542.